Ozempic 1MG (Semaglutide)

What is Ozempic 1mg (Semaglutide)?

Ozempic 1mg is a prescription medication containing the active ingredient Semaglutide, a GLP-1 receptor agonist. It is primarily prescribed to manage blood sugar levels in adults with type 2 diabetes mellitus and is also widely used for weight loss, especially in individuals with obesity or weight-related medical problems.

Manufactured by Novo Nordisk, Ozempic is administered as a once-weekly subcutaneous injection. It mimics the action of the natural hormone GLP-1 (glucagon-like peptide-1), stimulating insulin release, reducing appetite, and slowing gastric emptying.

Key Uses of Ozempic 1mg:

• Management of Type 2 Diabetes Mellitus

• Improving glycemic control alongside diet and exercise

• Supporting weight loss and reducing appetite

• Lowering risk of major cardiovascular events in people with type 2 diabetes and known heart disease

How Does Ozempic Work?

Ozempic works by mimicking GLP-1, a hormone your body naturally produces:

• Stimulates insulin secretion when blood sugar levels are high

• Suppresses glucagon release, reducing liver glucose production

• Slows gastric emptying, leading to reduced appetite

• Helps with weight management by promoting satiety

Because it is taken only once a week, Ozempic offers convenience, making it easier for patients to stick to their treatment plan.

Who Can Use Ozempic?

Ozempic is prescribed for:

• Adults with type 2 diabetes not adequately controlled by oral medications or lifestyle changes

• People who are overweight (BMI ≥27 kg/m²) with weight-related health issues such as hypertension or high cholesterol

• Adults with obesity (BMI ≥30 kg/m²) seeking effective medical weight loss support

Ozempic is not recommended for:

• Type 1 diabetes

• Children under 18

• People with a personal/family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Dosage and Administration:

• Typical Starting Dose: 0.25mg once weekly for 4 weeks (to reduce gastrointestinal side effects)

• Maintenance Dose: Gradually increased to 0.5mg and then 1mg weekly, based on tolerance and medical guidance

Ozempic should be injected subcutaneously (under the skin) in the abdomen, thigh, or upper arm. Rotate injection sites weekly. It can be taken with or without meals, at any time of the day.

Benefits of Ozempic 1mg:

• Significantly reduces HbA1c levels (a measure of long-term blood sugar)

• Aids in substantial weight loss (5–15% of body weight)

• Lowers the risk of heart attacks, stroke, and cardiovascular death

• Once-weekly dosing increases treatment adherence

• May reduce the need for insulin or additional medications

Side Effects of Ozempic:

Common side effects:

• Nausea

• Vomiting

• Diarrhea or constipation

• Headache

• Abdominal pain

• Fatigue

• Decreased appetite

Serious side effects (seek medical help):

• Pancreatitis (severe abdominal pain)

• Kidney problems

• Vision changes (especially in diabetics with retinopathy)

• Gallbladder issues

• Allergic reactions (rash, itching, swelling)

• Signs of thyroid tumor (lump in the neck, hoarseness, difficulty swallowing)

Precautions and Warnings:

• Inform your doctor if you have a history of thyroid cancer, pancreatitis, kidney disease, or diabetic retinopathy.

• Not suitable for pregnant or breastfeeding women unless prescribed.

• Monitor blood sugar levels regularly, especially if combined with other antidiabetic drugs.

• Risk of hypoglycemia increases when used with insulin or sulfonylureas.

Drug Interactions:

Inform your doctor or pharmacist about all medications you're taking. Common drug interactions include:

• Insulin or insulin secretagogues (risk of hypoglycemia)

• Other weight loss drugs

• Warfarin (may affect INR levels)

• Diuretics or other blood pressure medications

Storage Instructions:

• Before first use: Store in the refrigerator (2°C–8°C). Do not freeze.

• After first use: Store at room temperature (below 30°C) or refrigerate. Use within 56 days.

• Keep the pen capped and protected from light.